Abstract 7181: Gene enhancers as novel rationale therapeutic targets for impeding colorectal cancer progression

Flavia Genua, Sudipto Das(National Cancer Institute), Neville E. Sanjana(New York Genome Center), Sarah Maguire(The University of Sydney), Gráinne Kirwan, Christina M. Caragine(New York Genome Center), Paulien Van Minsel, Bernard Thienpont(Center for Human Genetics), Weipeng Wang(XinHua Hospital), Xinxin Shao(Shandong University of Technology), Ellen Finnegan
Cancer Research
April 21, 2025
10.1158/1538-7445.am2025-7181
Cited by 0

Related Papers

Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
|Cell|2015|934
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
|Nature|2016|662
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing
|Nature Genetics|2016|467
Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature
|Journal of Eating Disorders|2022|351
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336